Evidence map›Paper›PMID 40603242›Full record

ArticleHLA2025

Investigations of HLA-F and HLA-G 3'UTR Polymorphisms in Preeclampsia and Fetal Growth Restriction Indicate a Possible Role of HLA-F-HLA-G Haplotypes and Diplotypes.

Hiba Iraqi Møller, Camilla Moldrup Christiansen, Freja Rueholm Klok, Nanna Heldager Pedersen, Thomas Blauenfeldt, Katrine Folmann Finne, Henriette Svarre Nielsen, Thomas Vauvert F Hviid

Abstract read
In one paragraph

Article in HLA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hiba Iraqi MøllerCentre for Immune Regulation and Reproductive Immunology (CIRRI) and the ReproHealth Research Consortium ZUH, Department of Clinical Biochemistry, Zealand University Hospital, Roskilde, Denmark.ORCID 0000-0001-7915-6654
Camilla Moldrup ChristiansenCentre for Immune Regulation and Reproductive Immunology (CIRRI) and the ReproHealth Research Consortium ZUH, Department of Clinical Biochemistry, Zealand University Hospital, Roskilde, Denmark.
Freja Rueholm KlokCentre for Immune Regulation and Reproductive Immunology (CIRRI) and the ReproHealth Research Consortium ZUH, Department of Clinical Biochemistry, Zealand University Hospital, Roskilde, Denmark.
Nanna Heldager PedersenCentre for Immune Regulation and Reproductive Immunology (CIRRI) and the ReproHealth Research Consortium ZUH, Department of Clinical Biochemistry, Zealand University Hospital, Roskilde, Denmark.ORCID 0000-0003-1109-296X
Thomas BlauenfeldtCentre for Immune Regulation and Reproductive Immunology (CIRRI) and the ReproHealth Research Consortium ZUH, Department of Clinical Biochemistry, Zealand University Hospital, Roskilde, Denmark.
Katrine Folmann FinneDepartment of Obstetrics and Gynecology, Herlev Hospital, Herlev, Denmark.
Henriette Svarre NielsenDepartment of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Thomas Vauvert F HviidCentre for Immune Regulation and Reproductive Immunology (CIRRI) and the ReproHealth Research Consortium ZUH, Department of Clinical Biochemistry, Zealand University Hospital, Roskilde, Denmark.ORCID 0000-0003-0299-0151

Funding

Chief Physician Johan Boserup and Lise Boserup Fund J.nr. 20795-24Dagmar Marshalls FondEngineer K. A. Rohde and Wife's FundRegion of Southern Denmark and Region of Zealand Common FundRegion Zealand Health Sciences Research Foundation
6 · The paper itself

Abstract

HLA-F and HLA-G may be involved in the pathogeneses of preeclampsia and fetal growth restriction (FGR). However, the functions of HLA-F and HLA-G in placental dysfunction remain unclear. The aim was to investigate differences in the prevalence of specific HLA-F and HLA-G gene allelic polymorphisms, genotypes, haplotypes, and diplotypes between controls and cases with preeclampsia or FGR. In total, blood samples from 365 pregnant females (controls, n = 192; preeclampsia, n = 164; FGR, n = 19) in their second and third trimester, and corresponding cordial blood samples (reflecting newborns, n = 160) were obtained after delivery. Genomic DNA was sequenced with a focus on the specific gene polymorphisms in the HLA-F gene locus, especially the single nucleotide polymorphisms (SNPs) rs1362126 (G/A), rs2523405 (T/G) and rs2523393 (A/G), as well as the rs371194629 (14-bp ins/del) in the 3'UTR of HLA-G. Haplotype and diplotype distributions were obtained using PHASE v2.1, and linkage disequilibrium analyses were performed. SNPs in the HLA-F gene locus and the 3'UTR of HLA-G were not associated with the risk of preeclampsia or FGR. The SNPs did not correlate with fetal-placental weight ratio, deviation of birth weight at gestational age, and placental weight. However, a trend towards an absence of certain HLA-F-HLA-G extended diplotypes in preeclampsia was observed. The current study does not support associations of the investigated HLA-F SNPs with preeclampsia or FGR. However, further studies are needed to evaluate the possible role of certain fetal HLA-F-HLA-G extended haplotypes and diplotypes in preeclampsia.

Indexed as

3' Untranslated RegionsFetal Growth RetardationHaplotypesHistocompatibility Antigens Class IHLA-G AntigensPolymorphism, Single NucleotidePre-EclampsiaAdultAllelesCase-Control StudiesFemaleGene FrequencyGenetic Predisposition to DiseaseGenotypeHumansLinkage Disequilibrium3' Untranslated RegionsHistocompatibility Antigens Class IHLA-F antigensHLA-G Antigensfetal growth restrictiongene polymorphismsHLA‐FHLA‐Gpreeclampsia

Identifiers

PMID40603242
PMCPMC12221863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.